IP
SRTS icon

Invenire Partners’s Sensus Healthcare SRTS Stock Holding History

Invenire Partners’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.49M Buy
+118,867
New +$1.42M 2.28% 22

Other funds holding SRTS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invenire Partners's SRTS Position: Q3 2022 in Review

Invenire Partners opened a new position in Sensus Healthcare (SRTS) in Q3 2022: 118,867 shares worth $1.49M. The stake represents 2.28% of the portfolio and ranks #22 among its holdings.

81 funds tracked by Wall St. Rank hold SRTS as of Q3 2022.

  • Invenire Partners held 118,867 shares of Sensus Healthcare worth $1.49M as of Q3 2022.
  • Sensus Healthcare was a new Invenire Partners position in Q3 2022.
  • Sensus Healthcare made up 2.28% of Invenire Partners's portfolio in Q3 2022, its #22 holding.
  • 81 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2022.

Based on Invenire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.